放射学与非放射学中轴型脊柱关节炎疾病特征与负担的系统综述与荟萃分析
该系统综述与荟萃分析纳入60项研究,比较放射学中轴型脊柱关节炎(r-axSpA)与非放射学中轴型脊柱关节炎(nr-axSpA)患者的临床特征、疾病负担、治疗方式及疗效。结果显示r-axSpA患者更多为男性、吸烟者,病程和诊断延迟更长,外周表现更常见于nr-axSpA,而葡萄膜炎和MRI骶髂关节结构损伤更常见于r-axSpA;除r-axSpA活动度受限更明显外,两组疾病负担、治疗方式及疗效相似。
要点
- r-axSpA患者男性比例、吸烟比例、平均病程及诊断延迟均高于nr-axSpA。
- 外周表现更常见于nr-axSpA,葡萄膜炎和MRI骶髂关节结构损伤更常见于r-axSpA。
- 除r-axSpA的Bath强直性脊柱炎活动度指数更高外,两组疾病负担和治疗效果无显著差异。
核心结论
- r-axSpA与nr-axSpA临床特征相似,但外周受累更常见于nr-axSpA,r-axSpA活动度受限更明显,两组疾病负担、治疗方式及疗效相当。
研究设计与样本
- 系统文献综述(2009-2018年)采用PICO方法,纳入报告r-axSpA和nr-axSpA结局的60项研究,进行荟萃分析,根据异质性采用随机或固定效应模型。
主要发现
- r-axSpA患者男性占69.6% vs nr-axSpA 53.6%,吸烟者占37.7% vs 31.1%,平均病程8.6年 vs 5.0年,诊断延迟6.1年 vs 4.2年。
- 外周表现更常见于nr-axSpA,而葡萄膜炎和MRI骶髂关节结构损伤更常见于r-axSpA。
- r-axSpA的C反应蛋白和Bath强直性脊柱炎活动度指数更高,而Bath强直性脊柱炎疾病活动指数、功能指数和强直性脊柱炎生活质量在两组相似。
- 两组治疗 effect 无显著差异。
关键数值与推荐
- r-axSpA vs nr-axSpA:男性69.6% vs 53.6%,吸烟37.7% vs 31.1%,平均病程8.6 vs 5.0年,诊断延迟6.1 vs 4.2年。
- 外周表现更常见于nr-axSpA,葡萄膜炎和MRI骶髂关节结构损伤更常见于r-axSpA。
- r-axSpA的C反应蛋白和Bath强直性脊柱炎活动度指数更高,Bath强直性脊柱炎疾病活动指数、功能指数和强直性脊柱炎生活质量两组相似。
临床怎么用
- 临床识别中轴型脊柱关节炎时,应关注nr-axSpA患者的外周表现和r-axSpA患者的活动度受限及结构损伤。
- 治疗决策可参考两者疾病负担和疗效相似的特点,但需个体化评估外周受累和活动度。
局限性
- 研究异质性可能影响合并结果,纳入研究时间范围为2009-2018年,未涵盖更近期证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the clinical characteristics, burden of disease (eg, disease activity, function, quality of life), treatment modalities and treatment effect in patients with radiographic and non-radiographic axial Spondyloarthritis (r-axSpA and nr-axSpA). METHODS: A systematic literature review (2009-2018) was performed using the participants, intervention, comparator and outcomes methodology. Studies reporting outcomes (clinical presentation, burden of disease, treatment modalities and treatment effect) of both r-axSpA and nr-axSpA were included. A pooled analysis was performed (standardised means difference and relative risk for continuous and binary variables, respectively) and random or fixed effects methods were used depending on the heterogeneity of the studies. RESULTS: 60 studies out of 787 references were included. Pooled analysis showed that, compared with patients with nr-axSpA, patients with r-axSpA were more frequently men (69.6% vs 53.6%), smokers (37.7% vs 31.1%) and had higher mean disease duration (8.6 vs 5.0 years) and longer time to diagnosis (6.1 vs 4.2 years). Peripheral manifestations were more prevalent in nr-axSpA, while uveitis and structural damage on MRI of the sacroiliac joints were more prevalent in r-axSpA. C-reactive protein and the Bath Ankylosing Spondylitis Mobility Index were higher in r-axSpA, while Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Functional Index and Ankylosing Spondylitis Quality of Life were similar in both groups. No significant differences were found with regard to treatment effect. CONCLUSIONS: Patients with r-axSpA and nr-axSpA share a similar clinical presentation except for peripheral involvement, which is more prevalent among nr-axSpA. Except for a more impaired mobility in r-axSpA, both groups showed a comparable burden of disease, treatment modalities and treatment effect.
引用
- López-Medina C, Ramiro S, van der Heijde D, et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019. PMID: 31803500. doi:10.1136/rmdopen-2019-001108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。